A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats

A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats

Whereas, multiple vaccine types have been developed to curb the spread of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) among humans, there are very few vaccines being developed for animals including pets. To combat the threat of human-to-animal, animal-to-animal, and animal-to-human...

Full description

Bibliographic Details
Main Authors: Kairat Tabynov, Madiana Orynbassar, Leila Yelchibayeva, Nurkeldi Turebekov, Toktassyn Yerubayev, Nurali Matikhan, Tlektes Yespolov, Nikolai Petrovsky, Kaissar Tabynov
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Veterinary Science
Subjects:
cats
SARS-CoV-2
COVID-19
vaccine
adjuvant
spike protein
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2022.815978/full

Internet

https://www.frontiersin.org/articles/10.3389/fvets.2022.815978/full

Similar Items